Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Jan 28;22(4):1348-56.
doi: 10.3748/wjg.v22.i4.1348.

Hepatic non-parenchymal cells: Master regulators of alcoholic liver disease?

Affiliations
Review

Hepatic non-parenchymal cells: Master regulators of alcoholic liver disease?

Wonhyo Seo et al. World J Gastroenterol. .

Abstract

Chronic alcohol consumption is one of the most common causes of the progression of alcoholic liver disease (ALD). In the past, alcohol-mediated hepatocyte injury was assumed to be a significantly major cause of ALD. However, a huge number of recent and brilliant studies have demonstrated that hepatic non-parenchymal cells including Kupffer cells, hepatic stellate cells, liver sinusoidal endothelial cells and diverse types of lymphocytes play crucial roles in the pathogenesis of ALD by producing inflammatory mediators such as cytokines, oxidative stress, microRNA, and lipid-originated metabolites (retinoic acid and endocannabinoids) or by directly interacting with parenchymal cells (hepatocytes). Therefore, understanding the comprehensive roles of hepatic non-parenchymal cells during the development of ALD will provide new integrative directions for the treatment of ALD. This review will address the roles of non-parenchymal cells in alcoholic steatosis, inflammation, and liver fibrosis and might help us to discover possible therapeutic targets and treatments involving modulating the non-parenchymal cells in ALD.

Keywords: Alcoholic liver disease; Endocannabinoid; NADPH oxidase; Reactive oxygen stress.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Chronic ethanol consumption increases CYP2E1 expression in hepatocytes and apoptosis of activated hepatic stellate cells. Mice were fed with 5% liquid ethanol (EtOH) or isocaloric control (Pair-fed) diet for 8 wk. A: Liver tissues were stained with antibodies of CYP2E1 and α-smooth muscle actin (α-SMA). Hepatic stellate cells (HSCs) were freshly isolated from pair-fed and ethanol-fed mice; B: Liver tissues were stained with TUNEL and apoptotic bodies of non-parenchymal cells were counted. PT: Portal triad; N: Nucleus of hepatocyte. aP < 0.05 in comparison with the corresponding control.
Figure 2
Figure 2
Freshly isolated hepatic stellate cells from liquid ethanol-fed mice were susceptible to natural killer cell killing. A: Mice were fed with 5% liquid ethanol diet for 8 wk. Hepatic stellate cells (HSCs) were freshly isolated from ethanol-fed mice and then co-cultured with natural killer (NK) cells. NK cells were stained with NKG2D antibody and HSCs were stained with RAE1; B: Schematic overview of NKT cell cytotoxicity against activated HSCs via interferon (IFN)-γ-dependent manner.
Figure 3
Figure 3
Model of ethanol-mediated hepatic steatosis and inflammation and preventive effects of toll-like receptor 3 activation in hepatic stellate cells and Kupffer cells against alcoholic liver injury. HSCs: Hepatic stellate cells; EtOH: Ethanol; TLR3: Toll-like receptor 3; IL: Interleukin; LPS: Lipopolysaccharide; TNF-α: Tumor necrosis factor α; NF-κB: Nuclear factor kappa B.

Similar articles

Cited by

References

    1. O’Shea RS, Dasarathy S, McCullough AJ; Practice Guideline Committee of the American Association for the Study of Liver Diseases; Practice Parameters Committee of the American College of Gastroenterology. Alcoholic liver disease. Hepatology. 2010;51:307–328. - PubMed
    1. Purohit V, Gao B, Song BJ. Molecular mechanisms of alcoholic fatty liver. Alcohol Clin Exp Res. 2009;33:191–205. - PMC - PubMed
    1. Crabb DW, Matsumoto M, Chang D, You M. Overview of the role of alcohol dehydrogenase and aldehyde dehydrogenase and their variants in the genesis of alcohol-related pathology. Proc Nutr Soc. 2004;63:49–63. - PubMed
    1. Bechmann LP, Hannivoort RA, Gerken G, Hotamisligil GS, Trauner M, Canbay A. The interaction of hepatic lipid and glucose metabolism in liver diseases. J Hepatol. 2012;56:952–964. - PubMed
    1. Rui L. Energy metabolism in the liver. Compr Physiol. 2014;4:177–197. - PMC - PubMed

Publication types

MeSH terms